Faulkner C. Robert's most recent trade in Augmedix Inc was a trade of 12,879 Common Stock done . Disclosure was reported to the exchange on June 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Augmedix Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 12,879 | 41,461 | - | 0 | Common Stock | |
Augmedix Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 3,125 | 28,582 | - | 0 | Common Stock | |
Science 37 Holdings Inc
|
Robert C. Faulkner | Former Director | 12 Mar 2024 | 26,791 | 0 | - | 5.7 | 154,048 | Common Stock | |
Science 37 Holdings Inc
|
Robert C. Faulkner | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 2,068 | 0 | - | - | Stock Options (Right to Buy) | |
Augmedix Inc
|
Faulkner C. Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,767 | 25,457 | - | 0 | Common Stock | |
Augmedix Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 21,598 | 21,598 | - | 0 | Common Stock | |
Science 37 Holdings Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 0.25 per share. | 11 May 2023 | 494,853 | 535,836 | - | 0.3 | 125,000 | Common Stock |
Science 37 Holdings Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 3.05 per share. | 23 May 2022 | 40,983 | 40,983 | - | 3.0 | 124,998 | Common Stock |
Science 37 Holdings Inc
|
Robert C. Faulkner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 41,363 | 41,363 | - | - | Stock Option (Right to Buy) |